FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstaZeneca
- Posted on June 9, 2025
- By CNBC
- 4 Views
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstaZeneca
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
